AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | +11.1% | 188 | 0.0% | 0.00% | – |
| Q2 2023 | $9 | +28.6% | 188 | 0.0% | 0.00% | – |
| Q1 2023 | $7 | -30.0% | 188 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | -99.8% | 188 | +58.0% | 0.00% | – |
| Q3 2022 | $4,000 | +300.0% | 119 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 119 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 119 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 119 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 119 | +83.1% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 65 | -59.6% | 0.00% | – |
| Q3 2020 | $5,000 | +66.7% | 161 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 161 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 161 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | – | 161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |